In 2021, OUP and three licensing experts presented a 5-part comprehensive series on the basics of startup licenses out of academia. Join OUP, Certified Licensing Professionals, and our panel of experts for this “highlights” discussion as a refresher on academic startup licenses and updates on particular areas of negotiation. Topics include: • Field(s) of use…
For our sixth annual ‘Ask a VC’ webinar, OUP’s Life Science Managing Partner, Matt Cohen, and Technology Partner, Manny Stockman answered academic founder’s and our partner TTO’s questions on anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Since the purpose of this webinar was to answer questions…
Many universities now have Entrepreneur-in-Residence programs to help along nascent startups or aspiring academic founders. Experienced startup executives join these programs for various reasons and perform a variety of responsibilities to shepherd these early-stage opportunities. During this webinar, we spoke with three current EIRs: • Don Manfredi – University of Michigan • Julie Schoenfeld –…
Do you have a burning question on venture capital you need answered? Watch OUP’s fifth annual ‘Ask a VC’ webinar, a session where our partner TTOs can ask Managing Partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Since the purpose of…
Do you have a burning question on venture capital you need answered? Join OUP for our fourth annual ‘Ask a VC’ webinar, a session where our partner TTOs can ask Managing Partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Since the…
For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.
Join OUP for a webinar discussing models, structures, and best practices in raising pre-seed and seed funding for university startup companies from angels and accelerators. Our panel of experts will review their own models, which are distinct from each other in both the areas in which they invest as well as the additional value they provide. Other topics covered will include raising pre-seed and seed amounts, timing and structures for the raises, how to meet with these types of investors, the roles potentially played by these investors with the startups, and much more.
In January of 2020, the U.S. Federal Government issued final rules fully implementing the new powers granted to the Committee on Foreign Investment in the United States (CFIUS). Effective February 13, 2020, the Committee started to exercise its expanded ability to review the national security implications of more foreign investments – in particular companies with ‘novel or advanced technology’ including biotechnology, artificial intelligence, robotics, quantum computing, and advanced materials. New mandatory filing rules are now in place, and the Committee’s new enforcement team – charged with finding unfiled cases within CFIUS’s jurisdiction – is now bringing in far more cases than ever before.
Since its inception in 2009, OUP’s mission has been to foster deep partnerships with universities with three goals in mind: 1) to invest in their spinouts, 2) to help improve technology transfer effectiveness, and 3) to help improve research commercialization by connecting university startups to our network for funding and recruitment opportunities. Please join OUP for an upcoming webinar where we dive into specifics around how we work with our academic partners and continually work to achieve our mission.
A common practice across universities that hold equity in a company that IPOs is to sell all of its shares as soon as the lock up expires. But do the best returns necessarily come from selling all your stock immediately? When is the right time to sell stock in a therapeutics company?